Lymphtoxin β receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling

Pharmacological Research

Volumn 52, Issue 3, 2005, Pages 234-244

  An, Mao Mao ^a   Fan, Ke Xing ^a   Zhang, Jun Dong ^a   Li, Hai Jun ^a   Song, Shui Chuan ^a   Liu, Bin Guo ^a   Gao, Ping Hui ^a   Zhou, Qian ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; LIGHT; LT R; TNBS induced colitis

Indexed keywords

HERPESVIRUS ENTRY MEDIATOR; HYBRID PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIGHT PROTEIN; LYMPHTOXIN BETA RECEPTOR IMMUNOGLOBULIN; MESALAZINE; PROTEIN; RECEPTOR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL; CELL INFILTRATION; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; COLON; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; IMMUNOGLOBULINS; INTERLEUKIN-1; INTERLEUKIN-8; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; MALE; MEMBRANE PROTEINS; MESALAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECEPTORS, VIRUS; RNA, MESSENGER; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22144492189     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.03.009     Document Type: Article

References (57)

1. C.O. Oison, R.B. Sartor, G.S. Tennyson, and R.H. Ridell Experimental models of inflammatory bowel disease Gastroenterology 109 1995 1344 1367
2. R.B. Sartor Cytokines in intestinal inflammation: pathological and clinical considerations Gastroenterology 106 1994 533 549
3. R. Ettinger The role of tumor necrosis factor and lymphotoxin in lymphoid organ development Curr Top Microbiol Immunol 251 2000 203 210
4. P.D. Crowe, T.L. VanArsdale, B.N. Walter, C.F. Ware, C. Hession, and B. Ehrenfels A lymphotoxin-beta-specific receptor Science 264 1994 707 710
5. J.L. Browning, I. Dougas, A. Ngam-ek, P.R. Bourdon, B.N. Ehrenfels, and K. Miatkowski Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors J Immunol 154 1995 33 46
6. D.N. Mauri, R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, and G.L. Yu LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator Immunity 8 1998 21 30
7. Y. Zhai, R. Guo, T.L. Hsu, G.L. Yu, J. Ni, and B.S. Kwon LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer J Clin Invest 102 1998 1142 1151
8. Y.X. Fu, and D.D. Chaplin Development and maturation of secondary lymphoid tissues Annu Rev Immunol 17 1999 399 433
9. M. Gonzalez, F. Mackay, J.L. Browning, M.H. Kosco-Vilbois, and R.J. Noelle The sequential role of lymphotoxin and B cells in the development of splenic follicles J Exp Med 187 1998 997 1007
10. B.S. Kwon, K.B. Tan, J. Ni, K.O. Oh, Z.H. Lee, and K.K. Kim A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation J Biol Chem 272 1997 14272 14276
11. J. Wang, J.C. Lo, A. Foster, P. Yu, H.M. Chen, and Y. Wang The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT J Clin Invest 108 2001 1771 1780
12. P. Brandtzaeg Autoimmunity and ulcerative colitis: can two enigmas make sense together Gastroenterology 109 1995 307 312
13. R.B. Shaikh, S. Santee, S.W. Granger, K. Butrovich, T. Cheung, and M. Kronenberg Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction J Immunol 167 2001 6330 6337
14. C.O. Elson, and Y. Cong Understanding immune-microbial homeostasis in intestine Immunol Res 26 2002 87 94
15. M. Yoshida, Y. Shirai, T. Watanabe, M. Yamori, Y. Iwakura, and T. Chiba Differential localization of colitogenic Th1 and Th2 cells monospecific to a microflora-associated antigen in mice Gastroenterology 123 2002 1949 1961
16. T. Dohi, K. Fujihashi, H. Kiyono, C.O. Elson, and J.R. McGhee Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis Gastroenterology 119 2000 724 733
17. T. Dohi, P.D. Rennert, K. Fujihashi, H. Kiyono, Y. Shirai, and Y.I. Kawamura Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis J Immunol 167 2001 2781 2790
18. F. Mackay, J.L. Browning, P. Lawton, S.A. Shah, M. Comiskey, and A.K. Bhan Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis Gastroenterology 115 1998 1464 1475
19. P. Stopfer, F. Obermeier, N. Dunger, W. Falk, S. Farkas, and M. Janotta Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis Clin Exp Immunol 136 1 2004 21 29
20. K.L. Isaacs, R.B. Sartor, S. Haskill, and S. Haskill Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification Gastroenterology 103 1992 1587 1595
21. G. Rogler, and T. Andus Cytokines in inflammatory bowel disease World J Surg 22 4 1998 382 389
22. C.K. Ameho, A.A. Adjei, E.K. Harrison, K. Takeshita, T. Morioka, and Y. Arakaki Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis Gut 41 1997 487 493
23. A.R. Martin, I. Villegas, C. La Casa, and C. Alarcon de la Lastra The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats Eur J Pharmacol 481 2003 281 291
24. S.B. Abramson, and G. Weissmann The mechanisms of action of nonsteroidal antiinflammatory drugs Arthritis Rheum 32 1989 1 9
25. R.E. Small, and C.C. Schraa Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease Pharmacotherapy 14 1994 385 398
26. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
27. S.N. Murthy, H.S. Cooper, H. Shim, R.S. Shah, S.A. Ibrahim, and D.J. Sedergran Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin Dig Dis Sci 38 1993 1722 1734
28. L.A. Dieleman, M.J. Palmen, H. Akol, E. Bloemena, A.S. Pena, and S.G. Meuwissen Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines Clin Exp Immunol 114 1998 385 391
29. L. Tian, Y.X. Huang, M. Tian, W. Gao, and Q. Chang Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis World J Gastroenterol 9 2003 1028 1033
30. C. Linard, C. Marquette, J. Mathieu, A. Pennequin, D. Clarencon, and D. Mathe Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor Int J Radiat Oncol Biol Phys 58 2004 427 434
31. I. Monteleone, P. Vavassori, L. Biancone, G. Monteleone, and F. Pallone Immunoregulation in the gut: success and failures in human disease Gut 50 2002 II60 II64
32. F. Cottrez, S.D. Hurst, R.L. Coffman, and H. Groux T regulatory cells 1 inhibit a Th2-specific response in vivo J Immunol 165 2000 4848 4853
33. R.B. Sartor Innate immunity in the pathogenesis and therapy of IBD J Gastroenterol 38 2003 43 47
34. W. Strober, I.J. Fuss, and R.S. Blumberg The immunology of mucosal models of inflammation Annu Rev Immunol 20 2002 495 549
35. M.T. Abreu-Martin, and S.R. Targan Regulation of immune responses of the intestinal mucosa Crit Rev Immunol 16 1996 277 309
36. R. Duchmann, I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K.H. Meyer zum Buschenfelde Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol 102 1995 448 455
37. M.J. Blaser, R.A. Miller, J. Lacher, and J.W. Singleton Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens Gastroenterology 87 1984 888 894
38. + T cells reactive to enteric bacterial antigens in spontaneously colitis C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease J Exp Med 187 1998 855 864
39. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
40. M. Niessner, and B.A. Volk Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR) Clin Exp Immunol 101 1995 428 435
41. S.E. Plevy, C.J. Landers, J. Prehn, N.M. Carramanzana, R.L. Deem, and D. Shealy A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease J Immunol 159 1997 6276 6282
42. K.A. Papadakis, and S.R. Targan Role of cytokines in the pathogenesis of inflammatory bowel disease Annu Rev Med 51 2000 289 298
43. W. Strober, B. Kelsall, I. Fuss, T. Marth, B. Ludviksson, and R. Ehrhardt Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation Immunol Today 18 1997 61 64
44. G. Bisping, N. Lugering, S. Lutke-Brintrup, H.G. Pauels, G. Schurmann, and W. Domschke Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells Clin Exp Immunol 123 2001 15 22
45. R.M. Locksley, N. Killeen, and M.J. Lenardo The TNF and TNF receptor superfamilies: integrating mammalian biology Cell 104 2001 487 501
46. Y. Wang, J. Wang, Y. Sun, Q. Wu, and Y.X. Fu Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells J Immunol 166 2001 330 337
47. J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, and C. van Kooten The CD40 antigen and its ligand Annu Rev Immunol 12 1994 881 922
48. B. Kwon, C.H. Moon, S. Kang, S.K. Seo, and B.S. Kwon 4-1BB: still in the midst of darkness Mol Cells 10 2000 119 126
49. P. Schneider, F. MacKay, V. Steiner, K. Hofmann, J.L. Bodmer, and N. Holler BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth J Exp Med 189 1999 1747 1756
50. H.B. Shu, W.H. Hu, and H. Johnson TALL-1 is a novel member of the TNF family that is down-regulated by mitogens J Leukoc Biol 65 1999 680 683
51. F. Mackay, and S.L. Kalled TNF ligands and receptors in autoimmunity: an update Curr Opin Immunol 14 2002 783 790
52. J.A. Harrop, P.C. McDonnell, M. Brigham-Burke, S.D. Lyn, J. Minton, and K.B. Tan Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth J Biol Chem 273 1998 27548 27556
53. S.A. Marsters, T.M. Ayres, M. Skubatch, C.L. Gray, M. Rothe, and A. Ashkenazi Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1 J Biol Chem 272 1997 14029 14032
54. H. Bantel, C. Berg, M. Vieth, M. Stolte, W. Kruis, and K. Schulze-Osthoff Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis Am J Gastroenterol 95 2000 3452 3457
55. T. Dohi, K. Fujihashi, P.D. Rennert, K. Iwatani, H. Kiyono, and J.R. McGhee Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses J Exp Med 189 1999 1169 1180
56. O. Cohavy, J. Zhou, C.F. Ware, and S.R. Targan LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling J Immunol 174 2005 646 653
57. O. Cohavy, J. Zhou, S.W. Granger, C.F. Ware, and S.R. Targan LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine J Immunol 173 2004 251 258